Product image of Hemosol B0 (Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate) supplied by GNH India

Hemosol B0

Active Ingredient:
Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate
Origin:
EU

Hemosol B0 (Calcium, Lactic Acid, Magnesium, Sodium, Chloride Ion, Hydrogen Carbonate)

Hemosol B0 is a sterile solution for injection that contains calcium, lactic acid, magnesium, sodium, chloride ion, and hydrogen carbonate. It is supplied as an electrolyte solution intended for use in haemodialysis or intravenous administration. The product is manufactured for the European market and is classified as a prescription‑only renal replacement therapy agent. It provides essential electrolytes and a bicarbonate buffer to help maintain acid‑base balance during treatment.

Manufacturer / TM Owner

Vantive Belgium

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

Hemosol B0 is employed in clinical settings where rapid correction of electrolyte and acid‑base disturbances is required.

  • Hemodialysis procedures to replace lost electrolytes and maintain plasma bicarbonate.
  • Acute renal failure management when renal excretion of electrolytes is impaired.
  • Intravenous electrolyte replacement in patients with severe fluid and electrolyte losses.
  • Support of metabolic acidosis correction during renal replacement therapy.
  • Peri‑operative fluid management in surgeries with anticipated electrolyte shifts.

Side Effects

Adverse reactions to Hemosol B0 are generally infrequent, but they may vary in severity.

Common

  • Mild nausea or vomiting.
  • Transient headache.
  • Localized infusion site irritation or erythema.
  • Slight increase in serum calcium or magnesium levels without clinical symptoms.

Serious

  • Severe hyperkalemia or hypermagnesemia leading to cardiac arrhythmia.
  • Acute pulmonary edema from fluid overload.
  • Anaphylactic or severe hypersensitivity reaction.
  • Significant metabolic alkalosis requiring medical intervention.

Precautions & Warnings

When using Hemosol B0, clinicians should observe specific precautions to minimize risk.

  • Assess baseline electrolyte and acid‑base status before initiation.
  • Monitor serum calcium, magnesium, sodium, and bicarbonate levels regularly during therapy.
  • Adjust infusion rate in patients with compromised cardiac function or fluid overload risk.
  • Use caution in pregnant or lactating women; safety data are limited.
  • Avoid rapid administration that may cause sudden shifts in plasma osmolality.
  • Ensure compatibility with other intravenous solutions to prevent precipitation.

Avoid Interactions

Hemosol B0 may interact with certain medications or solutions; awareness of these interactions helps maintain safety.

Avoid

  • Concurrent use of calcium channel blockers that may exacerbate hypercalcemia.
  • High‑dose magnesium sulfate infusions, which can lead to additive hypermagnesemia.
  • Sodium‑containing medications that could precipitate fluid overload.

Use with caution

  • Loop diuretics, as they may alter electrolyte balance and require dose adjustments.
  • ACE inhibitors or ARBs, which affect renal handling of electrolytes.
  • Blood products or albumin solutions, requiring monitoring for electrolyte shifts.

Frequently Asked Questions

Hemosol B0 is a sterile solution for injection that can be administered intravenously or used as the dialysate fluid during haemodialysis.

The formulation contains calcium, magnesium, sodium, chloride ion, lactic acid, and hydrogen carbonate (bicarbonate).

It is indicated for haemodialysis, acute renal failure, and situations requiring intravenous electrolyte replacement.

Yes, the bicarbonate component helps correct metabolic acidosis by providing a buffering capacity during treatment.

Regular monitoring of serum electrolytes (calcium, magnesium, sodium) and acid‑base status is recommended, along with observation for fluid balance.

Safety data in pregnancy are limited; clinicians should weigh potential benefits against risks before use in pregnant patients.

Common side effects include mild nausea, transient headache, infusion site irritation, and minor, asymptomatic changes in electrolyte levels.

Serious events include severe hypercalcemia or hypermagnesemia, cardiac arrhythmias, pulmonary edema, anaphylaxis, and significant metabolic alkalosis.

Compatibility should be confirmed before mixing; incompatibility can lead to precipitation or loss of efficacy.

Unlike plain saline, Hemosol B0 provides a balanced mix of multiple electrolytes and a bicarbonate buffer, making it suitable for renal replacement therapy.

Contraindications include known hypersensitivity to any component and conditions where rapid electrolyte shifts could be harmful, such as uncontrolled cardiac failure.

Prescribing information is typically available from the manufacturer’s website or through national regulatory agencies.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.